⌘K

Login Start Free

Home/Filings/4/0001209191-18-058931

4//SEC Filing

Tepper Mark 4

Accession 0001209191-18-058931

CIK 0001595097other

View on SEC.gov Company Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 4:09 PM ET

Size

6.8 KB

Accession

0001209191-18-058931

Insider Transaction Report

Form 4

Period: 2018-11-14

Corbus Pharmaceuticals Holdings, Inc.CRBP

President and CSO

Transactions

Exercise/Conversion
Common Stock
2018-11-14$1.00/sh+10,000$10,000→ 2,110,400 total
Exercise/Conversion
Option to purchase common stock
2018-11-14−10,000→ 261,600 total
Exercise: $1.00From: 2015-04-11Exp: 2024-04-11→ Common Stock (10,000 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Corbus Pharmaceuticals Holdings, Inc.

CIK 0001595097

Entity typeother

Related Parties

1

filerCIK 0001291087

Filing Metadata

Form type: 4
Filed: Nov 15, 7:00 PM ET
Accepted: Nov 16, 4:09 PM ET
Size: 6.8 KB

View on SEC.gov